Globus Medical (GMED) Equity Average (2012 - 2026)

Globus Medical has reported Equity Average for 15 years, with the latest figure at $4.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 12.58% year-over-year to $4.7 billion; the trailing twelve-month figure through Mar 2026 stood at $4.7 billion (up 12.58% YoY), and the FY2025 full-year result was $4.4 billion, up 7.04% from the prior year.
• Equity Average for Q1 2026 stood at $4.7 billion, up from $4.5 billion in the prior quarter.
• The five-year high for Equity Average was $4.7 billion in Q1 2026, with the low at $1.7 billion in Q3 2022.
• Historically, Equity Average has averaged $3.3 billion across 5 years, with a median of $4.0 billion in 2024.
• Annual changes were most pronounced in 2023 — Equity Average jumped 126.71% — and 2024, when it grew 0.75%.
• Globus Medical's Equity Average stood at $1.8 billion in 2022, then jumped by 126.71% to $4.1 billion in 2023, then rose by 0.75% to $4.1 billion in 2024, then increased by 8.8% to $4.5 billion in 2025, then increased by 3.72% to $4.7 billion in 2026.
• The last three Equity Average figures came in at $4.7 billion (Q1 2026), $4.5 billion (Q4 2025), and $4.3 billion (Q3 2025), per Business Quant data.